Tech Company Financing Transactions
Crescendo Health Funding Round
Crescendo Health closed a $3.4 million Seed venture capital round on 1/19/2023. Investors included Define Ventures.
Transaction Overview
Company Name
Announced On
1/19/2023
Transaction Type
Venture Equity
Amount
$3,400,000
Round
Seed
Investors
Define Ventures (Lead Investor)
Proceeds Purpose
The company will use the funds to bring innovation into medical research by unlocking traditionally siloed health data.
Company Information
Company Status
Private & Independent
Industry
Healthcare IT
Mailing Address
18 Bartol St 980
San Francisco, CA 94133
USA
San Francisco, CA 94133
USA
Phone
Undisclosed
Website
Email Address
Overview
Crescendo was founded by Sam Roosz and Michael Glassman to enable better health outcomes for patients, while protecting the interests of research participants. This means bringing world-leading technologies in data security to clinical research and ensuring that every member of the Crescendo team feels proud to have our products deployed as part of future care for our loved ones. As a public benefit corporation, our corporate structure enables decisions that prioritize societal impact. We're here to enable research that is far more accessible to patients and clinicians, so that the costs of new research fall precipitously, and there are pathways to efficiently monitor the long-term safety and efficacy of new treatments.
Management Team
Title
Name
Email & Social
Browse more venture capital transactions:
Prev: 1/19/2023: Oro venture capital transaction
Next: 1/19/2023: Roth Industries venture capital transaction
Share this article
About Database of VC Transactions
We report on all VC transactions involving tech companies. VC investment data records on this site are sourced from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs